ASCO has elected five new members to the ASCO Board of Directors and the Nominating Committee for 4- and 3-year terms, respectively, starting in June 2021:
Gladys I. Rodriguez, MD
Taofeek K. Owonikoko, MD, PhD
Mariana Chavez Mac Gregor, MD, MSc
Merry Jennifer Markham, MD, FACP, FASCO
Nathan A. Pennell, MD, PhD, FASCO
Gladys I. Rodriguez, MD, has been elected to a Designated Community Oncologist seat on the Board. Dr. Rodriguez is Vice President of Clinical Research at South Texas Oncology and Hematology, PA.
Taofeek K. Owonikoko, MD, PhD, has been elected to a Designated Medical Oncologist seat on the Board. Dr. Owonikoko is Director of Thoracic Oncology at Winship Cancer Institute, and Professor and Vice Chair for Faculty Development at Emory University.
Mariana Chavez Mac Gregor, MD, MSc, has been elected to an Undesignated Specialty seat on the Board. Dr. Chavez Mac Gregor is Associate Professor in Health Services Research and Breast Medical Oncology at MD Anderson Cancer Center.
Merry Jennifer Markham, MD, FACP, FASCO, has been elected to an Undesignated Specialty seat on the Nominating Committee. Dr. Markham is Interim Chief of the Division of Hematology and Oncology and Professor at the University of Florida Health Cancer Center.
Nathan A. Pennell, MD, PhD, FASCO, has been elected to an Undesignated Specialty seat on the Nominating Committee. Dr. Pennell is Director, Lung Cancer Medical Oncology, at the Cleveland Clinic Foundation and Professor of Medicine at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
